Immunai
Curated by SignalDeveloper of next-generation of immunomodulatory therapeutics
Overview
Developer of next-generation of immunomodulatory therapeutics. It has a properitery therapeutic engine AMICA Annotated Multiomic Immune Cell Atlas that combines multi-omic single-cell analysis with machine learning and functional genomics to accelerates drug discovery and development for immune-modulating medicines.
Key facts
- Founded
- 2018
- Headquarters
- United States
- Stage
- Sign up to view
- Industry
- Health Technology
Business model
- 4 products and services
- Sign up to view
Contact
- Primary office
- Sign up to view
- Sign up to view
Open roles
32 rolesSenior I / II Computational Biologist
New York, United States · On-site · Internship
Data Infrastructure Team Lead
Ramat Gan, Tel Aviv District, Israel · On-site · Internship
AI Infrastructure Engineer
Ramat Gan, Tel Aviv District, Israel · On-site · Internship